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Ascites is a common manifestation of 
chronic liver disease, and it is useful to 
regard it as evidence of decompensation. 
An improved understanding of the path- 
ogenesis of ascites has led" to significant 
advances in its therapy. Like any therapy 
which is apparently effective, this is often 
applied with enthusiasm which, in turn, 
can be misguided and, at times, detrimen- 
tal. For this reason, the prime objective for 
the treatment of ascites should be clearly 
understood; it is this objective which has 
received scant attention in the past. 
There  is only one major therapeutic 
benefit to be derived from the treatment of 
ascites. Relief of ascites by diuresis will 
lower portal pressure and is, therefore, the 
best medical means known to us for the 
prevention of bleeding from esophageal 
varices (1). Lowering of portal pressure is 
achieved, to a much lesser extent, by 
paracentesis. Therefore,  the patient whose 
ascites is difficult, if not impossible, to 
relieve by the renal route is most likely to 
suffer a fatal variceal hemorrhage in the 
hospital. Trea tment  of ascites per se does 
not improve liver function, and may even 
result in liver injury, particularly due to 
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hypokalemia (2). Apart  from the important  
effect on portal pressure, and the cosmetic 
benefit which is of little clinical impor- 
tance, the treatment of ascites does little 
more than demonstrate that the liver is 
capable of responding to the pharmacolog- 
ic manipulat ions employed. 
It  has been found empirically useful to 
regard ascites as a special case of the appli- 
cation of Starling's law which was first 
enunciated in 1896 (3). This  law states: 
"The re  must, at any time, be a balance 
between the hydrostatic force of the blood 
in the capillaries and the osmotic attrac- 
tion of the blood for the surrounding 
fluid." This  has been given quanti tat ive 
expression by Atkinson and Losowsky, 
who found that if the intrasplenic pressure 
(an index of portal pressure) were plotted 
against the concentration of serum al- 
bumin, almost all patients with ascites fell 
above a certain line, while patients without  
ascites fell below that line (3). Again, the 
line may be expressed empirically by the 
following ratio: 
10 X serum albumin (g%) + 4 
intrasplenic pressure (cm H20)  
In normal individuals, this ratio is about  
4:5. If it falls below 1, ascites is likely to 
occur. Hence, the purpose of therapy is to 
raise this ratio. This  can be done by lower- 
ing intrasplenic pressure, by increasing the 
concentration of albumin in the serum, or 
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both. As has already been pointed out, the 
effective t rea tment  of ascites will, by itself, 
lower portal  pressure; hence, t reatment  
may be self-accelerating and self- 
perpetuat ing,  and will require modifica- 
tions in the regimen prescribed. 
I t  is useful to consider separately the 
denomina tor  and numera to r  of this ratio. 
T o  begin with the denominator ,  it should 
be recalled that, in patients with at least a 
mild or moderate  cirrhosis as judged on 
clinical grounds, bed rest alone will result 
in a significant fall in portal  pressure, and 
may thereby promote  diuresis. Th is  is less 
evident in patients with cirrhosis in whom 
the disease is judged to be severe (4). A 
portal  decompression operation,  undertak- 
en specifically for relief of ascites, is now 
hardly ever required, 1)ecause much of the 
therapy available can be directed at the 
numerator .  
It  is obvious that there is no effective way 
of enhancing a lbumin synthesis or of low- 
ering the rate of a lbumin  catabolism or 
loss. However,  in the ratio cited above, 
a lbumin  is presented as a concentrat ion 
which is being expressed in g/100 mt, and 
the alternative method to increase its con- 
centrat ion is to remove water. U p  to one- 
half or more of the total exchangeable 
a lbumin  in the body may reside in the 
ascitic fluid, and therefore nothing is 
gained, and much  may be lost, by paracen- 
tesis. T o  increase the concentrat ion of al- 
bnmin  in the serum, then, it is necessary to 
remove the excess of sodium that goes with 
it. 
It  is tempt ing and a common practice to 
proceed immediately  to a drug regimen. 
We consider this to be in error because 
certain f imdamentals  must  be applied to 
all patients with ascites. T h e  importance  of 
bed rest has already been mentioned.  Sec- 
ondly, by definition, these patients have too 
much water in their body. For this reason 
it is futile, and may be dangerous, to at- 
tempt  a diuretic program without water 
restriction. Such restriction need not be 
overly vigorous, and we generally find that 
patients  wilt tolerate quite well restriction 
to 1 l i ter/day.  The re  is no diuresis of any 
magni tude without  natriuresis, and these 
patients have an excess body sodium just as 
they have an excess body water (5). Again, 
it is futile to remove sodium by diuresis 
without  restricting sodium intake. Consid- 
ering that these patients, untreated, usually 
excrete either minimal  or undetectable 
amounts  of sodium, the so-called "no added 
salt" diet, which really implies an intake of 
about  3 or 4 g sodium/day,  is not sufficient. 
Depending on the degree of ascites, the 
diet should contain 800-1000 mg sodium. 
Patients with tense ascites should be given 
a 450-mg sodium diet, and a skilled dieti- 
tian can usually prepare a diet containing 
only 200 mg sodium. Furthermore,  the 
body potassium is often low. There  is really 
no potassium-sparing diuretic regimen 
which is also effective. There  are only 
regimens which are more potassium-losing 
than others (5). Supplementary potassium 
should be given as potassium chloride, in 
doses which should be monitored by the 
serum potassium concentration. I t  is not 
unusual  to require 120 m E q / d a y  or more. 
Finally, even with adequate replacement 
by potassium chloride, hypochloremic alka- 
losis may occur and can be corrected by 
adminis trat ion of lysine monohydrochlor-  
ide. One ounce of a 20~o solution, given 3 
or 4 times a day, will usually restore a 
chloride deficit. I t  follows that serum elec- 
trolytes should be monitored frequently 
and that abnormali t ies  should be corrected 
promptly,  I t  is impor tan t  to aim at a rate 
of weight loss which should average be- 
tween 1 and 2 pounds/day,  and treatment 
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should be adjusted accordingly. Accurate 
weighing of such a pat ient  at the same time 
of day is important .  
Having thus established the importance 
of bed rest, salt and water restriction, and 
potassium supplementat ion,  one can then 
proceed to the appropr ia te  drug regimen. 
Patients with mild to moderate  ascites may 
need no drugs at all, or, if necessary, almost 
any diuretic drug used alone may suffice. 
In patients with moderate  to severe as- 
cites, polypharmacy, which has fallen into 
disrepute elsewhere, is still indicated. This  
is based on the fact that commonly used 
diuretic agents act synergistically at differ- 
ent sites in the renal tubule," thereby inhib- 
iting tubular  reabsorption of sodium. An 
aldosterone antagonist, such as spironolac- 
tone, while not very effective alone, should 
be used in conjunction with a carbonic 
anhydrase inhibi tor  such as hydrochloro- 
thiazide, or alternatively, with furosemide. 
The  total dose of spironolactone is usually 
100 mg/day  with hydrochlorothiazide; 
furosemide is generally given in divided 
doses totalling about  120 mg/day.  These 
doses should be varied, depending on the 
patient 's  clinical response. Should such a 
program fail to achieve diuresis, the cause 
for this failure should be investigated. 
Quite often, it is due to the fact that the 
patient  either does not follow or possibly 
does not understand the regimen of fluid 
and salt restriction that has been 
prescribed. Many patients, part icularly al- 
coholics, are compulsive drinkers, and if 
they do not receive alcohol, they will drink 
water. At times, we have found it necessary 
to institute rigid policing measures, includ- 
ing around-the-clock supervision by a "sit- 
ter" and even the turning off of the water 
supply in the pat ient 's  toilet. The  best 
evidence of illict coinsumption of water 
can be obtained by comparison of intake 
and output  records with the weight chart. 
In  the truly refractory patient,  ethacryn- 
ic acid, starting with a close of about  5 mg, 
which is increased gradually to 50 mg every 
12 hours, in addition to the regimen al- 
ready prescribed, may be effective. Occa- 
sionally, as a temporary  measure, pred- 
nisone in doses of 30 mg/day ,  by causing 
inhibi t ion of antidiuretic hormone secre- 
tion, may help initiate diuresis (6). 
Thereafter ,  it can be withdrawn. If salt- 
poor  human  a lbumin  is used it should be 
given in a min imal  volume to main ta in  
fluid restriction. I t  is not very effective, 
because it is rapidly catabolized and still 
contains appreciable quanti t ies of sodium. 
We have hesitated to use osmotic diuretic 
agents such as Mannitol  because, if they 
are to be given at all, they must be given 
rapidly, and there is fear of inducing var- 
iceal bleeding if this is done. Given a 
cooperative patient,  conscientious adminis- 
tration of the dietary and drug program, 
and maintenance of normal  electrol~,te 
status, virtually all patients with ascites due 
to chronic liver disease will respond to this 
program. Once diuresis has been initiated, 
it is usually possible to modify the pharma-  
cologic program, to relax the dietary re- 
strictions, and then to moni tor  the patient 's  
condition and weight when he is being 
discharged. 
A new and more serious situation does 
arise once the pat ient  presents with severe 
hyponatremia.  This  hyponat remia  is dilu- 
t ional- - ie ,  due to the fact that  the pat ient  
has too much sodium dissolved in far too 
much water. T h e  tempta t ion  to treat this 
by infusing physiologic or hypertonic saline 
must  be resisted. If there is too much 
sodium dissolved in too little water, a more 
rigorous fluid restriction should be im- 
posed, while sodium restriction is 
maintained.  T h e  diuretic regimen may 
have to be intensified, and as long as the 
blood urea nitrogen (BUN) and creatinine 
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are normal, this condition can be cor- 
rected. 
A much more ominous situation arises 
when there is threatened renal failure. 
This is manifested by a rise in BUN, pos- 
sibly related to overproduction of urea by 
the liver in the face of hyponatremia (7), 
and later, by a rise in serum creatinine, 
oliguria and eventually anuria. At this 
state, at least 80~o of the patients will 
succumb. Tlle mechanism of renal failure 
is not fully understood, but it appears to 
be, at least in major part, due to increased 
vascular resistance of the afferent renal 
arteriole, and therefore to failure of glo- 
merular perfusion and of glomerular filtra- 
tion. The  tragedy of the situation is that 
the renal parenchyma per se is unimpaired. 
This has been proven in man by the suc- 
cessful transplantation of kidneys from pa- 
tients dying of or with renal failure second- 
ary to cirrhosis. In other words, the renal 
lesion is reversible, and there is nothing 
wrong with the kidney per se. It fails 
because it is joined in circulation to a 
failing liver. As a corollary, the lesions, if 
any, found at autopsy in these kidneys, are 
unimpressive. 
In  terms of treatment, such patients 
should be considered to be suffering from 
acute renal failure, and should be treated 
conservatively by withdrawal of diuretic 
and potassium medication, and by strict 
maintenance of fluid balance. A precipitat- 
ing or aggravating cause, such as infection, 
should be sought, and the record should be 
reviewed for evidence of a prior renal 
disease. More heroic measures, such as he- 
modialysis, should be considered only if 
there is an aggravating factor, such as an 
operation, which has precipitated this con- 
dition. In other words, a patient who has 
previous, relatively stable, chronic liver dis- 
ease and whose exacerbation can be traced 
to an identifiable and correctable cause 
should be given the benefit of hemodialysis. 
Diuretics are often blamed for precipitat- 
ing renal failure. There is no clear evi- 
dence to judge whether or not this is cor- 
rect. Renal failure secondary to liver dis- 
ease has been recognized since the nine- 
teenth century, and histologic evidence of 
nephrotoxicity is almost uniformly absent. 
However, in weighing risks against benefits, 
it is clear that excessive zeal in prescribing 
may do more harm than good. 
The  rate at which ascitic fluid can be 
mobilized from the peritoneal compart- 
ent is limited (8), and although the plas- 
ma volume, in patients with cirrhosis and 
ascites, is usually elevated, this could be 
reversed if the rate of diuresis is in excess 
of the rate at which fluid can be mobilized 
from the abdomen. As stated in the intro- 
ductory paragraph, tlle benefits of treat- 
ment of ascites are real, and by judicious 
management of the patient, these benefits 
can be achieved with little risk. 
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